Clinical Trials Directory

Trials / Completed

CompletedNCT03066323

Effect of Tea Extract on Post Prandial Blood Glucose

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
166 (actual)
Sponsor
Unilever R&D · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

This study is designed as a randomized, single blind (data evaluation), placebo controlled, full cross-over study and conducted in 166 (including 10% drop out) males and females, aged ≥ 18 and ≤ 65 and waist circumference of \>80 cm for women and \>94 cm for men (indicating increased risk of metabolic complications (WHO)) and having a sedentary lifestyle. Subjects will receive rice with a tea extract and rice without a tea extract. There will be three visits to the test facility: one screening visit and two intervention visits. During the intervention visits venous blood samples will be collected for the analysis of plasma glucose (t = -30m, -5m, 15m, 30m, 45m, 1h, 1h 30m, 2h and 3h, relative to the start of rice consumption ) and serum insulin (t = -5m, 30m, 1h, 2h and 3h). Between the two intervention visits subjects have an interval of one week. This interval is required to minimize subject discomfort from repeated blood sampling.

Conditions

Interventions

TypeNameDescription
OTHERRice with tea extractRice with tea extract
OTHERRice without tea extractRice without tea extract

Timeline

Start date
2017-01-01
Primary completion
2017-06-01
Completion
2017-06-01
First posted
2017-02-28
Last updated
2017-07-28

Locations

1 site across 1 country: Ireland

Source: ClinicalTrials.gov record NCT03066323. Inclusion in this directory is not an endorsement.